Esters-buliding-blocks

On July 15, 2022, Cai, Liqin; Wang, Weijun; Tong, Jingwen; Fang, Luping; He, Xingfen; Xue, Qi; Li, Yanhua published an article.Recommanded Product: 123-25-1 The title of the article was Changes of bioactive substances in lactic acid bacteria and yeasts fermented kiwifruit extract during the fermentation. And the article contained the following:

Probiotic fermented fruit extract is a new kind of food with potential health care efficacy. In this study, transformation of bioactive substances in Lactic acid bacteria (LAB) and yeast fermented kiwifruit extract were researched. The highest levels of total polyphenol, superoxide dismutase (SOD) were found in Lactobacillus paracasei LG0260 fermented kiwifruit extract with 2.31 ± 0.06 mgGAE/g, 369 ± 12.73 U.mL-1, resp. LAB fermented kiwifruit extract dramatically had a highest vitamin C (VitC) concentration during the fermentation, while yeast and natural fermented samples were decline steadily. Another interesting founding, a highest level of γ-aminobutyric acid (GABA) was found in Saccharomyces cerevisiae J2861 fermented kiwifruit extract with 24.132 ± 1.01μg/mL. Furthermore, the main organic acids in fresh kiwifruit and yeast fermented kiwifruit extract were citric acid and malic acid. However, lactic acid and citric acid were the main organic acids in LAB fermented kiwifruit extract A total of 43 kinds of flavor compounds in fresh kiwifruit and 88 kinds of flavor compounds in fermented kiwifruit extract were identified. Esters and alcs. in fermented kiwifruit system increased by the fermentation of selected bacteria which improved the taste and flavor. The experimental process involved the reaction of Diethyl succinate(cas: 123-25-1).Recommanded Product: 123-25-1

The Article related to lactic acid bacteria yeast kiwifruit extract fermentation bioactive substance, Food and Feed Chemistry: Fruits, Vegetables, Legumes, and Nuts and other aspects.Recommanded Product: 123-25-1

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

On November 13, 2008, Bonnert, Roger Victor; McInally, Thomas; Thom, Stephen published a patent.Product Details of 142327-44-4 The title of the patent was Preparation of imidazoquinolines as TLR7 immunomodulators. And the patent contained the following:

Title compounds I [R1 = (un)substituted alkyl; Z1 = alkylene or cycloalkylene; X1 = NR5, NCOR5, CONR5, NR5CO, SO2NR5, etc.; Y1 = single bond or alkylene; each R2 independently = halo, CN, OH, thiol, alkyl, etc.; R3 = (un)substituted alkyl; each Ra independently = halo, CN, OH, thiol, alkyl, hydroxyalkyl, etc.; R5 = H, 3- to 8-membered saturated heterocyclic ring, (un)substituted alkyl or cycloalkyl; or R5 = alkylene which may be linked to a carbon atom within a alkylene group Z1 so as to form a saturated 4- to 7-membered nitrogen containing ring; with the proviso; m, n, p and q independently = 0-2; A = monocyclic or bicyclic aryl or monocyclic or bicyclic heteroaryl], and their pharmaceutically acceptable salts, are prepared and disclosed as toll-like receptors (TLR7) modulators. Thus, e.g., II was prepared in 8 steps starting from 4-hydroxyquinoline. II exhibited pEC50 value of 6.5 in human TLR7 assay. Having immuno-modulating properties via TLR7, I are useful in the treatment of viral or allergic diseases and cancers, etc. The experimental process involved the reaction of Methyl 2-(3-formylphenyl)acetate(cas: 142327-44-4).Product Details of 142327-44-4

The Article related to imidazoquinoline preparation tlr7 immunomodulator allergy antiviral antitumor, Heterocyclic Compounds (More Than One Hetero Atom): Imidazoles and other aspects.Product Details of 142327-44-4

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Siedler, Solvej; Lindner, Steffen N.; Bringer, Stephanie; Wendisch, Volker F.; Bott, Michael published an article in 2013, the title of the article was Reductive whole-cell biotransformation with Corynebacterium glutamicum: improvement of NADPH generation from glucose by a cyclized pentose phosphate pathway using pfkA and gapA deletion mutants.Related Products of 3976-69-0 And the article contains the following content:

In this study, the potential of Corynebacterium glutamicum for reductive whole-cell biotransformation is shown. The NADPH-dependent reduction of the prochiral Me acetoacetate (MAA) to the chiral (R)-Me 3-hydroxybutyrate (MHB) by an alc. dehydrogenase from Lactobacillus brevis (Lbadh) was used as model reaction and glucose served as substrate for the regeneration of NADPH. Since NADPH is mainly formed in the oxidative branch of the pentose phosphate pathway (PPP), C. glutamicum was engineered to redirect carbon flux towards the PPP. Mutants lacking the genes for 6-phosphofructokinase (pfkA) or glyceraldehyde 3-phosphate dehydrogenase (gapA) were constructed and analyzed with respect to growth, enzyme activities, and biotransformation performance. Both mutants showed strong growth defects in glucose minimal medium. For biotransformation of MAA to MHB using glucose as reductant, strains were transformed with an Lbadh expression plasmid. The wild type showed a specific MHB production rate of 3.1 mmolMHB h-1 g and a yield of 2.7 molMHB mol. The ΔpfkA mutant showed a similar MHB production rate, but reached a yield of 4.8 molMHB mol, approaching the maximal value of 6 molNADPH mol expected for a partially cyclized PPP. The specific biotransformation rate of the ΔgapA mutant was decreased by 62 % compared to the other strains, but the yield was increased to 7.9 molMHB mol, which to our knowledge is the highest one reported so far for this mode of NADPH regeneration. As one fourth of the glucose was converted to glycerol, the exptl. yield was close to the theor. maximal yield of 9 molNADPH mol. The experimental process involved the reaction of (R)-Methyl 3-hydroxybutanoate(cas: 3976-69-0).Related Products of 3976-69-0

The Article related to corynebacterium nadph generation reductive biotransformation pfka gapa deletion, Fermentation and Bioindustrial Chemistry: Industrial Chemicals and other aspects.Related Products of 3976-69-0

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Chong, Zhen Yee; Sandanamsamy, Sylvia; Ismail, Nur Najihah; Mohamad, Suriyati; Hanafiah, Khayriyyah Mohd published an article in 2021, the title of the article was Bio-Guided fractionation of oil palm (Elaeis guineensis) fruit and interactions of compounds with first-line antituberculosis drugs against Mycobacterium tuberculosis H37Ra.SDS of cas: 3319-31-1 And the article contains the following content:

Natural products with antimycobacterial adjuvant potential may be utilized to address the rise of multidrug-resistant tuberculosis (TB). The antioxidant-rich oil palm (Elaeis guineensis) fruit (OPF) was investigated for antimycobacterial activity against Mycobacterium tuberculosis (MTB) H37Ra using bio-guided fractionation techniques, followed by determination of fractional inhibition index (FIC) with first-line anti-TB drugs. In vitro screening using microplate Alamar blue assay showed n-hexane and chloroform partitions of OPF mesocarp had a min. inhibitory concentration (MIC) of 400-800μg/mL. The n-hexane fraction contained nonanoic acid (C9H18O2), decanoic acid (C10H20O2), and dodecanoic acid (C12H24O2), identified by gas chromatog.-mass spectrometry, which all had an MIC of 50μg/mL. Nonanoic and decanoic acids had additive effects when combined with streptomycin (FIC index: 0.625) and rifampicin (FIC index: 0.75), resp. Isoniazid had a 16-fold increase in activity when combined with nonanoic acid and decanoic acid. The combination of nonanoic acid with streptomycin was bactericidal to 99.9% of MTB H37Ra by Day 7 of the time-kill assay, with structural damage of the cell wall observed using electron microscopy. Cytotoxicity assessment using Vero cells confirmed nonanoic acid had low toxicity with LC50 of > 200μg/mL. The bio-guided fractionation of OPF shows the presence of fatty acids with anti-TB adjuvant potential. The experimental process involved the reaction of Tris(2-ethylhexyl) benzene-1,2,4-tricarboxylate(cas: 3319-31-1).SDS of cas: 3319-31-1

The Article related to elaeis fruit decanoic dodecanoic acid antituberculosis cytotoxicity tuberculosis, Food and Feed Chemistry: Fruits, Vegetables, Legumes, and Nuts and other aspects.SDS of cas: 3319-31-1

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

On March 4, 2013, Kaboudin, Babak; Khodamorady, Minoo; Abedi, Yaghoub published an article.Application of 707-07-3 The title of the article was A Practical and Convenient Method for the Synthesis of Some Benzimidazoles. And the article contained the following:

A new method for the synthesis of some benzimidazoles by the reaction of o-phenylenediamines with orthoesters under solvent-free conditions without any additives such as base, acid or catalyst is reported. The experimental process involved the reaction of (Trimethoxymethyl)benzene(cas: 707-07-3).Application of 707-07-3

The Article related to phenylenediamine orthoester heterocyclization solventless, benzimidazole preparation, Heterocyclic Compounds (More Than One Hetero Atom): Imidazoles and other aspects.Application of 707-07-3

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Ivanovich, Ryan A.; Polat, Dilan E.; Beauchemin, Andre M. published an article in 2017, the title of the article was Oxygen-Substituted Isocyanates: Blocked (Masked) Isocyanates Enable Controlled Reactivity.COA of Formula: C9H11NO2 And the article contains the following content:

Oxygen-substituted isocyanates (O-isocyanates) are rare isocyanates with a reported propensity to trimerize, a side-reaction that severely limited their use in synthesis. Herein, the development of blocked (masked) O-isocyanate precursors that form this reactive intermediate in situ provide controlled reactivity, allowing the first examples of cascade reactions involving O-isocyanates. Complex hydroxylamine-derived hydantoins and dihydrouracil compounds can be rapidly assembled from α- and β-amino esters, illustrating the convenience of masked O-isocyanates as hydroxylamine derived building blocks. Evidence for the intermediacy of an O-isocyanate intermediate is provided. The experimental process involved the reaction of Methyl N-Methylanthranilate(cas: 85-91-6).COA of Formula: C9H11NO2

The Article related to hydantoin preparation, dihydrouracil preparation, amino ester isocyanate cyclization, Heterocyclic Compounds (More Than One Hetero Atom): Imidazoles and other aspects.COA of Formula: C9H11NO2

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

On June 21, 2012, McInally, Thomas; Pimm, Austen published a patent.Electric Literature of 142327-44-4 The title of the patent was Imidazo[4,5-c]quinolin-1-yl derivative useful in therapy, and preparation thereof. And the patent contained the following:

The invention provides the compound of formula I and pharmaceutically acceptable salt thereof, pharmaceutical compositions containing the compound and the use of the compound in therapy. Compound I is useful in the treatment of asthma, COPD, allergic rhinitis, allergic conjunctivitis, atopic dermatitis, cancer, hepatitis B, hepatitis C, HIV, HPV, bacterial infections, actinic keratosis or pre-cancerous skin lesions. The experimental process involved the reaction of Methyl 2-(3-formylphenyl)acetate(cas: 142327-44-4).Electric Literature of 142327-44-4

The Article related to imidazoquinoline preparation asthma copd cancer hepatitis allergic rhinitis treatment, Heterocyclic Compounds (More Than One Hetero Atom): Imidazoles and other aspects.Electric Literature of 142327-44-4

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

On March 2, 2006, Andrzej, Roman Batt; Baxter, Andrew John; Heeney, Celine; Stockley, Martin Lee; Bryan Roe, Michael; Hudson, Peter; Handy, Rachel published a patent.Electric Literature of 53838-27-0 The title of the patent was Preparation of tetraaza-benzo[f]azulenes as vasopressin V1a antagonists. And the patent contained the following:

The title compounds I [G = NR5R6, II-V; A1 = CH2, CH(OH), NH, N(alkyl), O and S; A2 = CH2, CH(OH), C(O), NH; A3, A12 = S, NH, N(alkyl), etc.; A4, A13 = CR9, N; A5, A14 = CR10, N; A6 = CH2, NH, N(alkyl), O; A7, A11 = C, N; A8, A9 = CH, N, NH, S, etc.; A10 = CH:CH, CH, N, NH, etc.; the ring constituted by A7-A11 is aromatic; R1-R3 = H, alkyl, O(alkyl), NO2, F, Cl, Br; R4 = H, alkyl, aryl, heteroaryl, etc.; R5, R6 = alkyl, aryl, (CH2)f-aryl, (CH2)f-heteroaryl; R9, R10 = H, alkyl, alkoxy, etc.; W = O, NH; X = (CH2)m, C(O), SOj; Y = O, S, NH, N(alkyl); a, f, j = 1-2; m = 0-2; with provisos] which are vasopressin V1a receptor antagonists, were prepared and formulated. E.g., a multi-step synthesis of 4-(3,3-dimethylbutyl)piperazine-1-carboxylic acid 4-(3,6-dimethyl-4,10-dihydro-3H-2,3,4,9-tetraaza-benzo[f]azulene-9-carbonyl)-2-fluorobenzylamide, starting from 4-(tert-butoxycarbonylamino-methyl)-3-fluorobenzoic acid and 3,6-dimethyl-3,4,9,10-tetrahydro-2,3,4,9-tetraazabenzo[f]azulene (preparations of the reactants was provided), was given. Compounds I were assayed to determine their ability to inhibit the cellular consequences of AVP stimulation on intact cells. In the assay, compounds I cause significant inhibition of cellular activation at concentrations of 30 μM or less. Preferred compounds I cause significant inhibition at concentrations of 300 nM. Pharmaceutical compositions of the compounds I are useful as treatment of dysmenorrhea. The experimental process involved the reaction of (S)-5-tert-Butyl 1-methyl 2-aminopentanedioate(cas: 53838-27-0).Electric Literature of 53838-27-0

The Article related to benzoazulene tetraaza triaza preparation vasopressin v1a antagonist dysmenorrhea treatment, Heterocyclic Compounds (More Than One Hetero Atom): Diazepines and other aspects.Electric Literature of 53838-27-0

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

On December 31, 1996, Molina, Pedro; Conesa, Carlota; Desamparados Velasco, M. published an article.COA of Formula: C18H17NO4 The title of the article was Iminophosphorane-mediated synthesis of 2-aminoimidazole derivatives. And the article contained the following:

A 1-pot synthesis of 4-substituted 2-aminoimidazoles based on the aza-Wittig reaction of 2-amino-3-azidoacrylates with isocyanates is described. The experimental process involved the reaction of Benzyl 2-(((benzyloxy)carbonyl)amino)acrylate(cas: 59524-07-1).COA of Formula: C18H17NO4

The Article related to aminoimidazole preparation, imidazole amino preparation, aminoazidoacrylate isocyanate aza wittig, Heterocyclic Compounds (More Than One Hetero Atom): Imidazoles and other aspects.COA of Formula: C18H17NO4

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

On April 27, 2000, Almansa, Carmen; Gonzalez, Concepcion; Torres, M<Safety of Ethyl 3-fluoro-4-methylbenzoate The title of the patent was Novel imidazoles with anti-inflammatory activity and their preparation and use. And the patent contained the following:

Title compounds I are disclosed [wherein one of X or Y = N; other = C; R1 = H, Me, halo, cyano, NO2, CHO, COCH3 or COOR4; R2 = (un)substituted aryl or heteroaryl; R3 = C1-8 alkyl, C1-8 haloalkyl, or NR4R6; R4 = H, C1-8 alkyl, or (un)substituted aryl(alkyl); R6 = H, C1-8 alkyl, arylalkyl, COR8, or CO2R8; R8 = C1-8 alkyl or C1-8 haloalkyl; aryl = Ph or naphthyl; heteroaryl = pyridyl, pyrazinyl, pyrimidinyl, or pyridazinyl, optionally fused to a benzene ring]. The compounds are useful as selective inhibitors of cyclooxygenase-2 (COX-2), and particularly as antiinflammatories. Claimed uses include treatment of inflammation, pain, fever, prostanoid-induced smooth muscle contraction, dysmenorrhea, premature labor, asthma, bronchitis, cancer (especially gastrointestinal or colon), cerebral infarct, epilepsy, or neurodegenerative diseases such as Alzheimer’s disease or dementia. For instance, 4-(MeSO2)C6H4NH2 was condensed with 4-FC6H4CHO under Dean-Stark conditions, and the resulting imine was cyclized with tosylmethyl isocyanide (75%), followed by imidazole ring chlorination with N-chlorosuccinimide (80%), to give the invention compound II. This compound gave 89% inhibition of COX-2 at 1 μM in vitro, but only 37.8% inhibition of COX-1 at 10 μM. The experimental process involved the reaction of Ethyl 3-fluoro-4-methylbenzoate(cas: 86239-00-1).Safety of Ethyl 3-fluoro-4-methylbenzoate

The Article related to imidazole preparation antiinflammatory cox2 inhibitor, cyclooxygenase 2 inhibitor imidazole preparation, Heterocyclic Compounds (More Than One Hetero Atom): Imidazoles and other aspects.Safety of Ethyl 3-fluoro-4-methylbenzoate

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics